While Retatrutide shows promise, its availability is still on the horizon
Therefore, starting retatrutide at a very low dose (1 mg or 2 mg) helps your body adjust and avoid gastrointestinal side effects
Should your organization invest in GLP-1s for employee weight loss
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH
Kristin Lovato, an obesity specialist at Banner Health, says she has seen how rapid weight loss affects physical conditioning
There are no fasting rules, no fluid restrictions, and no daily timing windows to manage